US2390529A
(en)
|
1942-02-03 |
1945-12-11 |
Ernst A H Friedheim |
Hydrazino-1,3,5-triazino derivatives of substituted phenylarsenic compounds
|
DE1252823B
(es)
|
1963-02-15 |
|
|
|
BE754242A
(fr)
|
1970-07-15 |
1971-02-01 |
Geigy Ag J R |
Diamino-s-triazines et dinitro-s-triazines
|
US3867383A
(en)
|
1971-03-29 |
1975-02-18 |
Ciba Geigy Corp |
Monoanthranilatoanilino-s-triazines
|
BE793501A
(fr)
|
1971-12-31 |
1973-06-29 |
Ciba Geigy |
Composes heterocycliques et produits phytopharmaceutiques qui en contiennent
|
CH606334A5
(es)
|
1974-06-21 |
1978-10-31 |
Ciba Geigy Ag |
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
JPS58186682A
(ja)
|
1982-04-27 |
1983-10-31 |
日本化薬株式会社 |
セルロ−ス又はセルロ−ス含有繊維材料の染色法
|
DE3512630A1
(de)
|
1985-04-06 |
1986-10-23 |
Hoechst Ag, 6230 Frankfurt |
Verfahren zum faerben oder bedrucken von cellulosefasern oder cellulosemischfasern
|
US5041443A
(en)
|
1989-02-21 |
1991-08-20 |
Dainippon Pharmaceutical Co., Ltd. |
Medicament for treating cerebral insufficiency diseases, novel 2-(1-piperazinyl)-4-phenylcycloalkanopyrimidine derivatives, and process for the production thereof
|
EP0385237B1
(en)
|
1989-03-03 |
1994-06-29 |
Dainippon Pharmaceutical Co., Ltd. |
2-(1-piperazinyl)-4-phenylcycloalkanopyridine derivatives, processes for the production thereof, and pharmaceutical composition containing the same
|
JPH0499768A
(ja)
|
1990-08-17 |
1992-03-31 |
Dainippon Pharmaceut Co Ltd |
4―(4―フェニルピリジン―2―イル)ピペラジン―1―オキシド誘導体
|
JPH05140126A
(ja)
|
1991-11-26 |
1993-06-08 |
Hokko Chem Ind Co Ltd |
トリアゾール誘導体および除草剤
|
CA2131004A1
(en)
|
1992-02-28 |
1993-09-02 |
Hideshi Kobayashi |
S-triazine derivative and remedy for estrogen-dependent disease containing said derivative as effective component
|
IL115420A0
(en)
|
1994-09-26 |
1995-12-31 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
IL117580A0
(en)
|
1995-03-29 |
1996-07-23 |
Merck & Co Inc |
Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them
|
WO1998021191A1
(fr)
|
1995-05-16 |
1998-05-22 |
Nissan Chemical Industries, Ltd. |
Derives de cyanoethylmelamine et procede de production
|
FR2735127B1
(fr)
|
1995-06-09 |
1997-08-22 |
Pf Medicament |
Nouvelles piperazines heteroaromatiques utiles comme medicaments.
|
ES2100129B1
(es)
|
1995-10-11 |
1998-02-16 |
Medichem Sa |
Nuevos compuestos aminopiridinicos policiclicos inhibidores de acetilcolinesterasa, procedimiento para su preparacion y su utilizacion.
|
GB9602166D0
(en)
|
1996-02-02 |
1996-04-03 |
Zeneca Ltd |
Aminoheterocyclic derivatives
|
EP0880501A1
(en)
|
1996-02-02 |
1998-12-02 |
Zeneca Limited |
Heterocyclic compounds useful as pharmaceutical agents
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
JPH09291034A
(ja)
|
1996-02-27 |
1997-11-11 |
Yoshitomi Pharmaceut Ind Ltd |
縮合ピリジン化合物およびその医薬としての用途
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
BR9709105A
(pt)
|
1996-05-20 |
1999-08-03 |
Darwin Discovery Ltd |
Sulfonamidas de quinolina como inibidoras de tnf e como inobidoras de pde-iv
|
US5984882A
(en)
|
1996-08-19 |
1999-11-16 |
Angiosonics Inc. |
Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy
|
US6399358B1
(en)
|
1997-03-31 |
2002-06-04 |
Thomas Jefferson University |
Human gene encoding human chondroitin 6-sulfotransferase
|
PT901786E
(pt)
|
1997-08-11 |
2007-08-07 |
Pfizer Prod Inc |
Disperções farmacêuticas sólidas com biodisponibilidade melhorada
|
JPH11158073A
(ja)
|
1997-09-26 |
1999-06-15 |
Takeda Chem Ind Ltd |
アデノシンa3拮抗剤
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
EP1042305B1
(en)
|
1997-12-22 |
2005-06-08 |
Bayer Pharmaceuticals Corp. |
INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS
|
AU9064598A
(en)
|
1998-07-10 |
2000-02-01 |
Harald Groger |
Precusors for pna-monomers
|
PT1588716E
(pt)
|
1998-08-06 |
2011-05-25 |
Mountain View Pharmaceuticals |
Conjugados de peg-urato oxidase e sua utiliza??o
|
US6783965B1
(en)
|
2000-02-10 |
2004-08-31 |
Mountain View Pharmaceuticals, Inc. |
Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
AU5379900A
(en)
|
1999-06-07 |
2000-12-28 |
Shire Biochem Inc. |
Thiophene integrin inhibitors
|
ATE309207T1
(de)
|
1999-08-27 |
2005-11-15 |
Sugen Inc |
Phosphat-mimetika sowie behandlungsmethoden unter verwendung von phosphatase-inhibitoren
|
CA2385592C
(en)
|
1999-09-17 |
2011-01-11 |
Bing-Yan Zhu |
Benzamides and related inhibitors of factor xa
|
BR0014078A
(pt)
|
1999-09-17 |
2002-12-31 |
Millennium Pharm Inc |
Inibidores de fator xa
|
DE60043397D1
(de)
|
1999-12-28 |
2010-01-07 |
Pharmacopeia Inc |
Cytokine, insbesondere tnf-alpha, hemmer
|
WO2001064642A2
(en)
|
2000-02-29 |
2001-09-07 |
Cor Therapeutics, Inc. |
Benzamides and related inhibitors of factor xa
|
BR0112631A
(pt)
|
2000-07-20 |
2003-09-23 |
Neurogen Corp |
Composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, pacote, métodos de reduzir a condutáncia de cálcio de um receptor de capsaicina e de tratar um mamìfero e uso de um composto
|
JP4113323B2
(ja)
|
2000-08-07 |
2008-07-09 |
富士フイルム株式会社 |
アゾ色素及びそれを含むインクジェット記録用インク、並びにインクジェット記録方法
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
EP1389194A2
(en)
|
2001-04-27 |
2004-02-18 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of bace
|
MXPA03011083A
(es)
|
2001-06-11 |
2004-07-08 |
Biovitrum Ab |
Compuestos de sulfonamida sustituida, procedimiento para su preparacion, y su uso como medicamento para el tratamiento de trastornos del sistema nervioso central. obesidad y diabetes tipo ii.
|
US7087614B2
(en)
|
2001-06-19 |
2006-08-08 |
Bristol-Myers Squibb Co. |
Pyrimidine inhibitors of phosphodiesterase (PDE) 7
|
WO2003016289A1
(en)
|
2001-08-17 |
2003-02-27 |
Ciba Specialty Chemicals Holding Inc. |
Triazine derivatives and their use as sunscreens
|
JP4753336B2
(ja)
|
2001-09-04 |
2011-08-24 |
日本化薬株式会社 |
新規アリル化合物及びその製法
|
US6878196B2
(en)
|
2002-01-15 |
2005-04-12 |
Fuji Photo Film Co., Ltd. |
Ink, ink jet recording method and azo compound
|
US20040067234A1
(en)
|
2002-07-11 |
2004-04-08 |
Paz Einat |
Isocitrate dehydrogenase and uses thereof
|
ES2392426T3
(es)
|
2002-07-18 |
2012-12-10 |
Janssen Pharmaceutica Nv |
Inhibidores de quinasas con triazina sustituida
|
JP2004083610A
(ja)
|
2002-08-22 |
2004-03-18 |
Fuji Photo Film Co Ltd |
インクセット、インクカートリッジ、記録方法、プリンター及び記録物
|
JP2004107220A
(ja)
|
2002-09-13 |
2004-04-08 |
Mitsubishi Pharma Corp |
TNF−α産生抑制剤
|
TWI335913B
(en)
|
2002-11-15 |
2011-01-11 |
Vertex Pharma |
Diaminotriazoles useful as inhibitors of protein kinases
|
WO2004050033A2
(en)
|
2002-12-02 |
2004-06-17 |
Arqule, Inc. |
Method of treating cancers
|
NZ541050A
(en)
|
2002-12-16 |
2010-06-25 |
Genmab As |
Human monoclonal antibodies against interleukin 8 (IL-8)
|
BRPI0406667A
(pt)
|
2003-01-10 |
2005-12-20 |
Threshold Pharmaceuticals Inc |
Método para o tratamento de câncer, e, formulação terapeuticamente aceitável de 2-dg
|
US7358262B2
(en)
|
2003-01-29 |
2008-04-15 |
Whitehead Institute For Biomedical Research |
Identification of genotype-selective anti-tumor agents
|
WO2004074438A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
WO2004073619A2
(en)
|
2003-02-14 |
2004-09-02 |
Smithkline Beecham Corporation |
Ccr8 antagonists
|
JP4629657B2
(ja)
|
2003-04-11 |
2011-02-09 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
11β−ヒドロキシステロイドデヒドロゲナーゼ1型化活性化合物
|
JP4889489B2
(ja)
|
2003-08-06 |
2012-03-07 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼのインヒビターとして有用なアミノトリアゾール化合物
|
WO2005035507A2
(en)
|
2003-10-10 |
2005-04-21 |
Bayer Pharmaceuticals Corporation |
4-aminopyrimidine derivatives for treatment of hyperproliferative disorders
|
JP4099768B2
(ja)
|
2003-11-10 |
2008-06-11 |
富士電機デバイステクノロジー株式会社 |
電子写真感光体および該電子写真感光体に起因する干渉縞有無の判定方法
|
US20070196395A1
(en)
|
2003-12-12 |
2007-08-23 |
Mackerell Alexander |
Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
|
EP1708712A1
(en)
|
2003-12-24 |
2006-10-11 |
Scios, Inc. |
Treatment of malignant gliomas with tgf-beta inhibitors
|
JP2005264016A
(ja)
|
2004-03-19 |
2005-09-29 |
Fuji Photo Film Co Ltd |
インクジェット記録用インク、インクセット及びインクジェット記録方法
|
US7335770B2
(en)
|
2004-03-24 |
2008-02-26 |
Reddy U5 Therapeutics, Inc. |
Triazine compounds and their analogs, compositions, and methods
|
GB0412526D0
(en)
|
2004-06-05 |
2004-07-14 |
Leuven K U Res & Dev |
Type 2 diabetes
|
JP5149009B2
(ja)
|
2004-09-20 |
2013-02-20 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
ヒトステアロイル−CoAデサチュラーゼを阻害するためのピリダジン誘導体
|
AU2005286592A1
(en)
|
2004-09-23 |
2006-03-30 |
Reddy Us Therapeutics, Inc. |
Novel pyrimidine compounds, process for their preparation and compositions containing them
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
US20100160324A1
(en)
|
2004-12-30 |
2010-06-24 |
Astex Therapeutics Limited |
Pyrazole derivatives as that modulate the activity of cdk, gsk and aurora kinases
|
EP1924573A1
(en)
|
2005-01-25 |
2008-05-28 |
AstraZeneca AB |
B-raf inhibitors
|
SG161248A1
(en)
|
2005-04-11 |
2010-05-27 |
Savient Pharmaceuticals Inc |
A variant form of urate oxidase and use thereof
|
EP1899486A4
(en)
|
2005-06-08 |
2009-07-22 |
Millennium Pharm Inc |
METHOD FOR IDENTIFYING, ASSESSING AND TREATING PATIENTS IN CANCER THERAPY
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
WO2007023186A1
(en)
|
2005-08-26 |
2007-03-01 |
Laboratoires Serono S.A. |
Pyrazine derivatives and use as pi3k inhibitors
|
US8133900B2
(en)
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
TW200815426A
(en)
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
US8343548B2
(en)
|
2006-08-08 |
2013-01-01 |
Shin-Etsu Chemical Co., Ltd. |
Solid dosage form comprising solid dispersion
|
US20100297673A1
(en)
|
2006-09-20 |
2010-11-25 |
Reddy Us Therapeutics |
Methods and compositions for upregulation of peroxiredoxin activity
|
US20080109846A1
(en)
|
2006-10-23 |
2008-05-08 |
Ewertz C Christian |
System and method for audiovisual content playback
|
JP2010508300A
(ja)
|
2006-10-26 |
2010-03-18 |
フライン、ギャリー・エー. |
アクアポリン修飾因子並びに浮腫および体液平衡異常の治療のためのそれらの使用方法
|
HUP0600810A3
(en)
|
2006-10-27 |
2008-09-29 |
Richter Gedeon Nyrt |
New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
|
PE20081229A1
(es)
|
2006-12-01 |
2008-08-28 |
Merck & Co Inc |
Antagonistas de receptor de orexina de diazepam sustituido
|
EP2121662A1
(en)
|
2006-12-04 |
2009-11-25 |
Neurocrine Biosciences, Inc. |
Substituted pyrimidines as adenosine receptor antagonists
|
AU2007330478B2
(en)
*
|
2006-12-06 |
2011-09-08 |
Conatus Pharmaceuticals, Inc. |
Crystalline forms of ( 3 S ) -3- [N- (N' - (2-tert-butylphenyl) oxamyl) alaninyl] amino-5- (2 ', 3 ', 5 ', 6 ' -tetrafluorophenoxy) -4-oxopentanoic acid
|
CA2913963A1
(en)
|
2006-12-08 |
2008-06-19 |
Millenium Pharmaceuticals, Inc. |
Unit dose formulations and methods of treating thrombosis with an oral factor xa inhibitor
|
CN101583365B
(zh)
|
2006-12-15 |
2012-09-26 |
阿布拉西斯生物科学公司 |
三嗪衍生物及其治疗应用
|
US8258295B2
(en)
|
2007-04-30 |
2012-09-04 |
Prometic Biosciences Inc. |
Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
|
EP2166849A4
(en)
|
2007-06-11 |
2010-09-15 |
Miikana Therapeutics Inc |
SUBSTITUTED PYRAZOL COMPOUNDS
|
CA2693901C
(en)
|
2007-07-20 |
2015-12-29 |
Nerviano Medical Sciences S.R.L. |
Substituted indazole derivatives active as kinase inhibitors
|
AU2008279097B2
(en)
|
2007-07-25 |
2013-05-02 |
Bristol-Myers Squibb Company |
Triazine kinase inhibitors
|
TW200906818A
(en)
|
2007-07-31 |
2009-02-16 |
Astrazeneca Ab |
Chemical compounds
|
BRPI0818366A2
(pt)
|
2007-10-10 |
2015-04-07 |
Takeda Pharmaceutical |
Composto, pró-droga, medicamento, método inibidor de faah, métodos de profilaxia ou tratamento para ansiedade, ou depressão, ou de alívio da dor, e de profilaxia ou tratamento para dor inflamatória ou dor neuropática, e, uso do composto.
|
AU2008345225A1
(en)
|
2007-12-21 |
2009-07-09 |
University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
JP5277685B2
(ja)
|
2008-03-26 |
2013-08-28 |
富士ゼロックス株式会社 |
電子写真感光体、画像形成装置、プロセスカートリッジ及び画像形成方法
|
GB0805477D0
(en)
|
2008-03-26 |
2008-04-30 |
Univ Nottingham |
Pyrimidines triazines and their use as pharmaceutical agents
|
US20090281089A1
(en)
|
2008-04-11 |
2009-11-12 |
Genentech, Inc. |
Pyridyl inhibitors of hedgehog signalling
|
CN101575408B
(zh)
|
2008-05-09 |
2013-10-30 |
Mca技术有限公司 |
用作阻燃剂和光稳定剂的聚三嗪基化合物
|
PL3782612T3
(pl)
|
2008-05-15 |
2024-03-04 |
Celgene Corporation |
Doustne formulacje analogów cytydyny i sposoby ich zastosowania
|
FR2932483A1
(fr)
|
2008-06-13 |
2009-12-18 |
Cytomics Systems |
Composes utiles pour le traitement des cancers.
|
WO2010007756A1
(ja)
|
2008-07-14 |
2010-01-21 |
塩野義製薬株式会社 |
Ttk阻害作用を有するピリジン誘導体
|
PL2328618T3
(pl)
*
|
2008-08-13 |
2018-06-29 |
Vertex Pharmaceuticals Incorporated |
Kompozycja farmaceutyczna n-[2,4-bis(1,1-dimetyloetylo)5-hydroksyfenylo]-1,4-dihydro-4-oksochinolino-3-karboksyamidu i jej podawanie
|
US20100144722A1
(en)
|
2008-09-03 |
2010-06-10 |
Dr. Reddy's Laboratories Ltd. |
Novel heterocyclic compounds as gata modulators
|
JP5421374B2
(ja)
|
2008-09-03 |
2014-02-19 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
悪性神経膠腫におけるイソクエン酸デヒドロゲナーゼ遺伝子および他の遺伝子の遺伝子変化
|
JP2010079130A
(ja)
|
2008-09-29 |
2010-04-08 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
US20100273808A1
(en)
|
2008-11-21 |
2010-10-28 |
Millennium Pharmaceticals, Inc. |
Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disorders
|
JP2010181540A
(ja)
|
2009-02-04 |
2010-08-19 |
Fuji Xerox Co Ltd |
電子写真感光体、プロセスカートリッジ、及び画像形成装置
|
RU2535217C2
(ru)
|
2009-02-06 |
2014-12-10 |
Ниппон Синяку Ко., Лтд. |
Производные аминопиразина и лекарственные средства
|
CN108524505A
(zh)
|
2009-03-13 |
2018-09-14 |
安吉奥斯医药品有限公司 |
用于细胞增殖相关病症的方法和组合物
|
DK2427441T3
(en)
|
2009-05-04 |
2017-03-20 |
Agios Pharmaceuticals Inc |
PKM2 Activators for use in the treatment of cancer
|
WO2010130638A1
(en)
|
2009-05-14 |
2010-11-18 |
Evotec Ag |
Sulfonamide compounds, pharmaceutical compositions and uses thereof
|
CN102573485B
(zh)
*
|
2009-06-08 |
2014-11-26 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
JP2012529527A
(ja)
|
2009-06-09 |
2012-11-22 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
ウレイドフェニル置換トリアジン誘導体類及びそれらの治療応用
|
CN102573487A
(zh)
|
2009-06-09 |
2012-07-11 |
加利福尼亚资本权益有限责任公司 |
Hedgehog信号传导的吡啶基-三嗪抑制剂
|
KR101712035B1
(ko)
|
2009-06-29 |
2017-03-03 |
아지오스 파마슈티컬스 아이엔씨. |
치료용 화합물 및 조성물
|
WO2011005209A1
(en)
|
2009-07-10 |
2011-01-13 |
Milux Holding S.A. |
Knee joint device and method
|
CA2772194A1
(en)
|
2009-09-01 |
2011-03-10 |
Pfizer Inc. |
Benzimidazole derivatives
|
CA2773561A1
(en)
|
2009-09-14 |
2011-03-17 |
Phusis Therapeutics Inc. |
Pharmaceutical compositions and formulations including inhibitors of the pleckstrin homology domain and methods for using same
|
JP5473851B2
(ja)
|
2009-09-30 |
2014-04-16 |
富士フイルム株式会社 |
高分子フィルム、位相差フィルム、偏光板及び液晶表示装置
|
US8652534B2
(en)
*
|
2009-10-14 |
2014-02-18 |
Berry Pharmaceuticals, LLC |
Compositions and methods for treatment of mammalian skin
|
EP3064595B1
(en)
|
2009-10-21 |
2019-02-27 |
Agios Pharmaceuticals, Inc. |
Methods for cell-proliferation-related disorders
|
CN105153188B
(zh)
|
2009-10-22 |
2018-06-01 |
法博太科制药有限公司 |
抗纤维化剂的稠环类似物
|
EP2509600B1
(en)
|
2009-12-09 |
2017-08-02 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation
|
NZ578968A
(en)
|
2010-02-10 |
2011-03-31 |
Allans Sheetmetal And Engineering Services |
Fuel feed system for a pellet fire
|
US20130197106A1
(en)
|
2010-04-01 |
2013-08-01 |
Agios Pharmaceuticals, Inc |
Methods of identifying a candidate compound
|
US20130109643A1
(en)
*
|
2010-05-10 |
2013-05-02 |
The Johns Hopkins University |
Metabolic inhibitor against tumors having an idh mutation
|
US10064885B2
(en)
|
2010-07-09 |
2018-09-04 |
Massachusetts Institute Of Technology |
Metabolic gene, enzyme, and flux targets for cancer therapy
|
ES2704862T3
(es)
|
2010-07-16 |
2019-03-20 |
Agios Pharmaceuticals Inc |
Composiciones terapéuticamente activas y su método de uso
|
RU2598606C3
(ru)
*
|
2010-10-21 |
2021-12-20 |
МЕДИВЭЙШН ТЕКНОЛОДЖИЗ ЭлЭлСи |
Кристаллическая тозилатная соль (8s,9r)-5-фтор-8-(4-фторфенил)-9-(1-метил-1н-1,2,4-триазол-5-ил)-8-9-дигидро-2н-пиридо[4,3,2-de]фталазин-3(7н)-она
|
WO2012078288A2
(en)
|
2010-11-08 |
2012-06-14 |
Washington University |
Methods of determining risk of adverse outcomes in acute myeloid leukemia
|
SG10201601507YA
(en)
|
2010-11-29 |
2016-04-28 |
Galleon Pharmaceuticals Inc |
Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
EP2691391A4
(en)
|
2011-03-29 |
2014-09-10 |
Broad Inst Inc |
COMPOUNDS AND METHODS FOR THE TREATMENT OF DISEASES RELATED TO ISOCITRATE DEHYDROGENASE
|
CN103608016A
(zh)
|
2011-05-03 |
2014-02-26 |
安吉奥斯医药品有限公司 |
丙酮酸激酶激活剂在治疗中的用途
|
TW201636330A
(zh)
|
2011-05-24 |
2016-10-16 |
拜耳知識產權公司 |
含有硫醯亞胺基團之4-芳基-n-苯基-1,3,5-三氮雜苯-2-胺
|
CA2834610A1
(en)
|
2011-06-06 |
2012-12-13 |
Merck Sharp & Dohme Corp. |
Rna interference mediated inhibition of isocitrate dehydrogenase (idh1) gene expression
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827170A
(zh)
*
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
US9199962B2
(en)
|
2011-07-07 |
2015-12-01 |
Merck Patent Gmbh |
Substituted azaheterocycles for the treatment of cancer
|
WO2013007708A1
(en)
|
2011-07-08 |
2013-01-17 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Medicament for treatment of liver cancer
|
US9167820B2
(en)
|
2011-07-22 |
2015-10-27 |
University Of Louisville Research Foundation, Inc. |
Anti-biofilm compounds
|
CN102659765B
(zh)
|
2011-12-31 |
2014-09-10 |
沈阳药科大学 |
嘧啶及三嗪类化合物的制备方法和应用
|
MX358940B
(es)
*
|
2012-01-06 |
2018-09-10 |
Agios Pharmaceuticals Inc Star |
Compuestos terapéuticamente activos y sus métodos de uso.
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
EP2804850B1
(en)
|
2012-01-19 |
2018-08-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
EP2634259A1
(en)
|
2012-03-01 |
2013-09-04 |
Deutsches Krebsforschungszentrum |
Means and methods for the determination of (D)-2-hydroxyglutarate (D2HG)
|
IN2014MN01897A
(es)
|
2012-03-09 |
2015-07-10 |
Carna Biosciences Inc |
|
WO2013138237A1
(en)
|
2012-03-12 |
2013-09-19 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for the diagnosis, prognosis and treatment of acute myeloid leukemia
|
WO2014015422A1
(en)
*
|
2012-07-27 |
2014-01-30 |
Ontario Institute For Cancer Research |
Cellulose-based nanoparticles for drug delivery
|
AU2013331626B2
(en)
|
2012-10-15 |
2018-08-02 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
US10376510B2
(en)
|
2013-07-11 |
2019-08-13 |
Agios Pharmaceuticals, Inc. |
2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015127173A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
WO2015127172A1
(en)
|
2014-02-20 |
2015-08-27 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
CA2942070A1
(en)
|
2014-03-14 |
2015-09-17 |
Agios Pharmaceuticals, Inc. |
Pharmaceutical compositions of therapeutically active compounds
|
NZ723859A
(en)
|
2014-03-14 |
2023-01-27 |
Servier Lab |
Pharmaceutical compositions of therapeutically active compounds and their uses
|
CA3002067C
(en)
|
2015-10-15 |
2023-11-28 |
Agios Pharmaceuticals, Inc. |
Combination therapy for treating malignancies
|
EP3362066B1
(en)
|
2015-10-15 |
2021-10-06 |
Les Laboratoires Servier SAS |
Combination therapy for treating malignancies
|
CA3002029A1
(en)
|
2015-10-15 |
2017-04-20 |
Celgene Corporation |
Combination therapy for treating malignancies
|
CA3007218A1
(en)
|
2015-12-04 |
2017-06-08 |
Agios Pharmaceuticals, Inc. |
Methods of treatment of malignancies
|
CN109069410B
(zh)
|
2016-02-26 |
2022-05-31 |
安吉奥斯医药品有限公司 |
用于治疗血液恶性肿瘤和实体瘤的idh1抑制剂
|
EP3512519A1
(en)
|
2016-09-14 |
2019-07-24 |
Gilead Sciences, Inc. |
Syk inhibitors
|